Application of surface-enhanced Raman spectroscopy for detection of beta amyloid using nanoshells

被引:65
作者
Beier, Hope T.
Cowan, Christopher B.
Chou, I-Hsien
Pallikal, James
Henry, James E.
Benford, Melodie E.
Jackson, Joseph B.
Good, Theresa A.
Cote, Gerard L.
机构
[1] Texas A&M Univ, Dept Biomed Engn, College Stn, TX 77843 USA
[2] Univ Maryland, Dept Chem & Biochem Engn, Baltimore, MD USA
[3] Nanospectra Biosci Inc, Houston, TX USA
基金
美国国家卫生研究院; 美国国家科学基金会;
关键词
surface-enhanced Raman spectroscopy; SERS; Raman spectroscopy; nanoshells; beta-amyloid; Alzheimer's disease; Congo red; self-assembled monolayer; ALZHEIMERS-DISEASE; FIBRIL FORMATION; MOUSE MODEL; CONGO RED; SCATTERING; PEPTIDE; BINDING; PROTEIN; BRAIN; TOXICITY;
D O I
10.1007/s11468-007-9027-x
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
Currently, no methods exist for the definitive diagnosis of AD premortem. beta-amyloid, the primary component of the senile plaques found in patients with this disease, is believed to play a role in its neurotoxicity. We are developing a nanoshell substrate, functionalized with sialic acid residues to mimic neuron cell surfaces, for the surface-enhanced Raman detection of beta-amyloid. It is our hope that this sensing mechanism will be able to detect the toxic form of beta-amyloid, with structural and concentration information, to aid in the diagnosis of AD and provide insight into the relationship between beta-amyloid and disease progression. We have been successfully able to functionalize the nanoshells with the sialic acid residues to allow for the specific binding of beta-amyloid to the substrate. We have also shown that a surface-enhanced Raman spectroscopy response using nanoshells is stable and concentration-dependent with detection into the picomolar range.
引用
收藏
页码:55 / 64
页数:10
相关论文
共 59 条
  • [1] Characterization of high-affinity binding between gangliosides and amyloid β-protein
    Ariga, T
    Kobayashi, K
    Hasegawa, A
    Kiso, M
    Ishida, H
    Miyatake, T
    [J]. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2001, 388 (02) : 225 - 230
  • [2] Progress in plasmonic engineering of surface-enhanced Raman-scattering substrates toward ultra-trace analysis
    Baker, GA
    Moore, DS
    [J]. ANALYTICAL AND BIOANALYTICAL CHEMISTRY, 2005, 382 (08) : 1751 - 1770
  • [3] Peripherally administered antibodies against amyloid β-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease
    Bard, F
    Cannon, C
    Barbour, R
    Burke, RL
    Games, D
    Grajeda, H
    Guido, T
    Hu, K
    Huang, JP
    Johnson-Wood, K
    Khan, K
    Kholodenko, D
    Lee, M
    Lieberburg, I
    Motter, R
    Nguyen, M
    Soriano, F
    Vasquez, N
    Weiss, K
    Welch, B
    Seubert, P
    Schenk, D
    Yednock, T
    [J]. NATURE MEDICINE, 2000, 6 (08) : 916 - 919
  • [4] Peripheral treatment with enoxaparin, a low molecular weight heparin, reduces plaques and β-amyloid accumulation in a mouse model of Alzheimer's disease
    Bergamaschini, L
    Rossi, E
    Storini, C
    Pizzimenti, S
    Distaso, M
    Perego, C
    De Luigi, A
    Vergani, C
    De Simoni, MG
    [J]. JOURNAL OF NEUROSCIENCE, 2004, 24 (17) : 4181 - 4186
  • [5] Efficient reversal of Alzheimer's disease fibril formation and elimination of neurotoxicity by a small molecule
    Blanchard, BJ
    Chen, A
    Rozeboom, LM
    Stafford, KA
    Weigele, P
    Ingram, VM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2004, 101 (40) : 14326 - 14332
  • [6] CSF biomarkers for mild cognitive impairment
    Blennow, K
    [J]. JOURNAL OF INTERNAL MEDICINE, 2004, 256 (03) : 224 - 234
  • [7] Projections of Alzheimer's disease in the United States and the public health impact of delaying disease onset
    Brookmeyer, R
    Gray, S
    Kawas, C
    [J]. AMERICAN JOURNAL OF PUBLIC HEALTH, 1998, 88 (09) : 1337 - 1342
  • [8] Acceleration of amyloid fibril formation by specific binding of A beta-(1-40) peptide to ganglioside-containing membrane vesicles
    ChooSmith, LP
    GarzonRodriguez, W
    Glabe, CG
    Surewicz, WK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (37) : 22987 - 22990
  • [9] Natural oligomers of the amyloid-protein specifically disrupt cognitive function
    Cleary, JP
    Walsh, DM
    Hofmeister, JJ
    Shankar, GM
    Kuskowski, MA
    Selkoe, DJ
    Ashe, KH
    [J]. NATURE NEUROSCIENCE, 2005, 8 (01) : 79 - 84
  • [10] THE CONSORTIUM TO ESTABLISH A REGISTRY FOR ALZHEIMERS-DISEASE (CERAD) .3. RELIABILITY OF A STANDARDIZED MRI EVALUATION OF ALZHEIMERS-DISEASE
    DAVIS, PC
    GRAY, L
    ALBERT, M
    WILKINSON, W
    HUGHES, J
    HEYMAN, A
    GADO, M
    KUMAR, AJ
    DESTIAN, S
    LEE, C
    DUVALL, E
    KIDO, D
    NELSON, MJ
    BELLO, J
    WEATHERS, S
    JOLESZ, F
    KIKINIS, R
    BROOKS, M
    [J]. NEUROLOGY, 1992, 42 (09) : 1676 - 1680